Achieve Life Sciences, Inc.
achievelifesciences.comWhat Do They Do?
Develops cytisinicline, a drug candidate for treating nicotine dependence in people seeking to quit smoking or vaping.
10-K for FY2025, filed Mar 24, 2026
Who Are Their Customers?
Plans to target prescribers and patients in the U.S. through digital promotion and field and virtual sales representatives; its commercial strategy may also use partners, distributors, a contract sales force or its own sales infrastructure, and it intends to seek partners outside the U.S.
10-K for FY2025, filed Mar 24, 2026We believe we will be able to commercialize independently in the U.S. market by focusing our marketing and sales efforts on highly targeted…View ↗
SALES AND MARKETINGView ↗
Our commercial strategy may include the use of strategic partners, distributors, a contract sale force or the establishment of our own…View ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 11, 2026
−$74.8MView ↗
- ▲ +488% (Loss)
- vs −$12.7M in Q2 FY2025
-
May 12, 2026
Names a new CEO as the board chair prepares to step down
Andrew D. Goldberg was appointed CEO; Thomas King planned to resign as board chair, with Lucian Iancovici set to take over.
Sources
8-K, filed May 12, 2026
Appointed Andrew D. Goldberg, MD as Chief Executive Officer and a Board member. New directors Christopher Martin, Lucian Iancovici, MD, and…View ↗
U.S. commercialization plan
The older report described commercialization either directly or through strategic collaborations; the latest report plans an independent U.S. launch using targeted marketing, digital tools, and field and virtual sales representatives.
10-K for FY2022, filed Mar 16, 2023 10-K for FY2025, filed Mar 24, 2026Our management team has significant experience in growing emerging companies focused on the development of under-utilized pharmaceutical…View ↗
We believe we will be able to commercialize independently in the U.S. market by focusing our marketing and sales efforts on highly targeted…View ↗
Who Do They Compete With?
Competes with Pfizer and GlaxoSmithKline
10-K for FY2025, filed Mar 24, 2026Only two non-nicotine, prescription treatments for smoking cessation are currently available in the United States; “varenicline” (marketed…View ↗
Loading...
